Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer

BJU International

Volumn 108, Issue 11, 2011, Pages 1716-1722

  Afaq, Asim ^a   Koh, Dow Mu ^a   Padhani, Anwar ^b   Van As, Nicholas ^a   Sohaib, S Aslam ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

cancer; diffusion; MRI; prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; WATER;

ARTICLE; BONE METASTASIS; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; GLEASON SCORE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MEDICAL LITERATURE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; T2 WEIGHTED MAGNETIC RESONANCE IMAGING; TREATMENT RESPONSE;

DIFFUSION MAGNETIC RESONANCE IMAGING; FORECASTING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 81255152010     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10256.x     Document Type: Article

References (20)

1. Haider MA, Amoozadeh Y, Jhaveri KS,. DW-MRI for disease characterization in the pelvis. In, Koh DM, Thoeny HC, eds, Diffusion-Weighted MR Imaging: Applications in the Body, Chapt 9. Berlin: Springer-Verlag, 2010: 143-56
2. Zelhof B, Pickles M, Liney G, et al,. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 2009; 103: 883-8
3. Yoshimitsu K, Kiyoshima K, Irie H, et al,. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 2008; 27: 132-9
4. Rosenkrantz AB, Kopec M, Kong X, et al. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging 2010; 31: 1387-94
5. Park BK, Lee HM, Kim CK, Choi HY, Park JW,. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol 2008; 43: 789-93
6. Portalez D, Rollin G, Leandri P, et al,. Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol 2010; 20: 2781-90
7. deSouza NM, Riches SF, Vanas NJ, et al,. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 2008; 63: 774-82
8. van As NJ, de Souza NM, Riches SF, et al. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. Eur Urol 2009; 56: 981-7
9. Park SY, Kim CK, Park BK, Lee HM, Lee KS,. Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results. Eur Radiol 2011; 21: 1111-8
10. Ren J, Huan Y, Wang H, et al,. Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol 2009; 19: 2481-6
11. Ren J, Huan Y, Li F, et al,. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma. J Magn Reson Imaging 2009; 30: 351-6
12. Mir N, Sohaib SA, Collins D, Koh DM,. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J Med Imaging Radiat Oncol 2010; 54: 358-64
13. Eiber M, Beer AJ, Holzapfel K, et al,. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 2010; 45: 15-23
14. Luboldt W, Kufer R, Blumstein N, et al,. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 2008; 249: 1017-25
15. Gutzeit A, Doert A, Froehlich JM, et al. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 2010; 39: 333-43
16. Song I, Kim CK, Park BK, Park W,. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. AJR Am J Roentgenol 2010; 194: W477-82
17. Kim CK, Park BK, Lee HM,. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 2009; 29: 391-7
18. Kim CK, Park BK, Lee HM, Kim SS, Kim E,. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol 2008; 190: 1180-6 (Pubitemid 351684917)
19. Reischauer C, Froehlich JM, Koh DM, et al,. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps-initial observations. Radiology 2010; 257: 523-31
20. Gurses B, Tasdelen N, Yencilek F, et al,. Diagnostic utility of DTI in prostate cancer. Eur J Radiol 2010; [Epub ahead of print]